Global characterization of copy number variants in epilepsy patients from whole genome sequencing

Jean Monlong, Simon L. Girard, Caroline Meloche, Maxime Cadieux-Dion, Danielle M. Andrade, Ron G. Lafreniere, Micheline Gravel, Dan Spiegelman, Alexandre Dionne-Laporte, Cyrus Boelman, Fadi F. Hamdan, Jacques L. Michaud, Guy Rouleau, Berge A. Minassian, Guillaume Bourque, Patrick Cossette

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number variants (CNVs) studies of epilepsy have used array-based technology and were restricted to the detection of large or exonic events. In contrast, whole-genome sequencing (WGS) has the potential to more comprehensively profile CNVs but existing analytic methods suffer from limited accuracy. We show that this is in part due to the non-uniformity of read coverage, even after intra-sample normalization. To improve on this, we developed PopSV, an algorithm that uses multiple samples to control for technical variation and enables the robust detection of CNVs. Using WGS and PopSV, we performed a comprehensive characterization of CNVs in 198 individuals affected with epilepsy and 301 controls. For both large and small variants, we found an enrichment of rare exonic events in epilepsy patients, especially in genes with predicted loss-of-function intolerance. Notably, this genome-wide survey also revealed an enrichment of rare non-coding CNVs near previously known epilepsy genes. This enrichment was strongest for non-coding CNVs located within 100 Kbp of an epilepsy gene and in regions associated with changes in the gene expression, such as expression QTLs or DNase I hypersensitive sites. Finally, we report on 21 potentially damaging events that could be associated with known or new candidate epilepsy genes. Our results suggest that comprehensive sequence-based profiling of CNVs could help explain a larger fraction of epilepsy cases.

Original languageEnglish (US)
Article numbere1007285
JournalPLoS Genetics
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

epilepsy
Epilepsy
genome
Genome
gene
multiple use
Genes
gene expression
genes
deoxyribonuclease I
application coverage
Deoxyribonuclease I
quantitative trait loci
Technology
Gene Expression
sampling
detection

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research

Cite this

Monlong, J., Girard, S. L., Meloche, C., Cadieux-Dion, M., Andrade, D. M., Lafreniere, R. G., ... Cossette, P. (2018). Global characterization of copy number variants in epilepsy patients from whole genome sequencing. PLoS Genetics, 14(4), [e1007285]. https://doi.org/10.1371/journal.pgen.1007285

Global characterization of copy number variants in epilepsy patients from whole genome sequencing. / Monlong, Jean; Girard, Simon L.; Meloche, Caroline; Cadieux-Dion, Maxime; Andrade, Danielle M.; Lafreniere, Ron G.; Gravel, Micheline; Spiegelman, Dan; Dionne-Laporte, Alexandre; Boelman, Cyrus; Hamdan, Fadi F.; Michaud, Jacques L.; Rouleau, Guy; Minassian, Berge A.; Bourque, Guillaume; Cossette, Patrick.

In: PLoS Genetics, Vol. 14, No. 4, e1007285, 01.04.2018.

Research output: Contribution to journalArticle

Monlong, J, Girard, SL, Meloche, C, Cadieux-Dion, M, Andrade, DM, Lafreniere, RG, Gravel, M, Spiegelman, D, Dionne-Laporte, A, Boelman, C, Hamdan, FF, Michaud, JL, Rouleau, G, Minassian, BA, Bourque, G & Cossette, P 2018, 'Global characterization of copy number variants in epilepsy patients from whole genome sequencing', PLoS Genetics, vol. 14, no. 4, e1007285. https://doi.org/10.1371/journal.pgen.1007285
Monlong J, Girard SL, Meloche C, Cadieux-Dion M, Andrade DM, Lafreniere RG et al. Global characterization of copy number variants in epilepsy patients from whole genome sequencing. PLoS Genetics. 2018 Apr 1;14(4). e1007285. https://doi.org/10.1371/journal.pgen.1007285
Monlong, Jean ; Girard, Simon L. ; Meloche, Caroline ; Cadieux-Dion, Maxime ; Andrade, Danielle M. ; Lafreniere, Ron G. ; Gravel, Micheline ; Spiegelman, Dan ; Dionne-Laporte, Alexandre ; Boelman, Cyrus ; Hamdan, Fadi F. ; Michaud, Jacques L. ; Rouleau, Guy ; Minassian, Berge A. ; Bourque, Guillaume ; Cossette, Patrick. / Global characterization of copy number variants in epilepsy patients from whole genome sequencing. In: PLoS Genetics. 2018 ; Vol. 14, No. 4.
@article{efaee142608c4a6aab4708b1a49648be,
title = "Global characterization of copy number variants in epilepsy patients from whole genome sequencing",
abstract = "Epilepsy will affect nearly 3{\%} of people at some point during their lifetime. Previous copy number variants (CNVs) studies of epilepsy have used array-based technology and were restricted to the detection of large or exonic events. In contrast, whole-genome sequencing (WGS) has the potential to more comprehensively profile CNVs but existing analytic methods suffer from limited accuracy. We show that this is in part due to the non-uniformity of read coverage, even after intra-sample normalization. To improve on this, we developed PopSV, an algorithm that uses multiple samples to control for technical variation and enables the robust detection of CNVs. Using WGS and PopSV, we performed a comprehensive characterization of CNVs in 198 individuals affected with epilepsy and 301 controls. For both large and small variants, we found an enrichment of rare exonic events in epilepsy patients, especially in genes with predicted loss-of-function intolerance. Notably, this genome-wide survey also revealed an enrichment of rare non-coding CNVs near previously known epilepsy genes. This enrichment was strongest for non-coding CNVs located within 100 Kbp of an epilepsy gene and in regions associated with changes in the gene expression, such as expression QTLs or DNase I hypersensitive sites. Finally, we report on 21 potentially damaging events that could be associated with known or new candidate epilepsy genes. Our results suggest that comprehensive sequence-based profiling of CNVs could help explain a larger fraction of epilepsy cases.",
author = "Jean Monlong and Girard, {Simon L.} and Caroline Meloche and Maxime Cadieux-Dion and Andrade, {Danielle M.} and Lafreniere, {Ron G.} and Micheline Gravel and Dan Spiegelman and Alexandre Dionne-Laporte and Cyrus Boelman and Hamdan, {Fadi F.} and Michaud, {Jacques L.} and Guy Rouleau and Minassian, {Berge A.} and Guillaume Bourque and Patrick Cossette",
year = "2018",
month = "4",
day = "1",
doi = "10.1371/journal.pgen.1007285",
language = "English (US)",
volume = "14",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Global characterization of copy number variants in epilepsy patients from whole genome sequencing

AU - Monlong, Jean

AU - Girard, Simon L.

AU - Meloche, Caroline

AU - Cadieux-Dion, Maxime

AU - Andrade, Danielle M.

AU - Lafreniere, Ron G.

AU - Gravel, Micheline

AU - Spiegelman, Dan

AU - Dionne-Laporte, Alexandre

AU - Boelman, Cyrus

AU - Hamdan, Fadi F.

AU - Michaud, Jacques L.

AU - Rouleau, Guy

AU - Minassian, Berge A.

AU - Bourque, Guillaume

AU - Cossette, Patrick

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number variants (CNVs) studies of epilepsy have used array-based technology and were restricted to the detection of large or exonic events. In contrast, whole-genome sequencing (WGS) has the potential to more comprehensively profile CNVs but existing analytic methods suffer from limited accuracy. We show that this is in part due to the non-uniformity of read coverage, even after intra-sample normalization. To improve on this, we developed PopSV, an algorithm that uses multiple samples to control for technical variation and enables the robust detection of CNVs. Using WGS and PopSV, we performed a comprehensive characterization of CNVs in 198 individuals affected with epilepsy and 301 controls. For both large and small variants, we found an enrichment of rare exonic events in epilepsy patients, especially in genes with predicted loss-of-function intolerance. Notably, this genome-wide survey also revealed an enrichment of rare non-coding CNVs near previously known epilepsy genes. This enrichment was strongest for non-coding CNVs located within 100 Kbp of an epilepsy gene and in regions associated with changes in the gene expression, such as expression QTLs or DNase I hypersensitive sites. Finally, we report on 21 potentially damaging events that could be associated with known or new candidate epilepsy genes. Our results suggest that comprehensive sequence-based profiling of CNVs could help explain a larger fraction of epilepsy cases.

AB - Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number variants (CNVs) studies of epilepsy have used array-based technology and were restricted to the detection of large or exonic events. In contrast, whole-genome sequencing (WGS) has the potential to more comprehensively profile CNVs but existing analytic methods suffer from limited accuracy. We show that this is in part due to the non-uniformity of read coverage, even after intra-sample normalization. To improve on this, we developed PopSV, an algorithm that uses multiple samples to control for technical variation and enables the robust detection of CNVs. Using WGS and PopSV, we performed a comprehensive characterization of CNVs in 198 individuals affected with epilepsy and 301 controls. For both large and small variants, we found an enrichment of rare exonic events in epilepsy patients, especially in genes with predicted loss-of-function intolerance. Notably, this genome-wide survey also revealed an enrichment of rare non-coding CNVs near previously known epilepsy genes. This enrichment was strongest for non-coding CNVs located within 100 Kbp of an epilepsy gene and in regions associated with changes in the gene expression, such as expression QTLs or DNase I hypersensitive sites. Finally, we report on 21 potentially damaging events that could be associated with known or new candidate epilepsy genes. Our results suggest that comprehensive sequence-based profiling of CNVs could help explain a larger fraction of epilepsy cases.

UR - http://www.scopus.com/inward/record.url?scp=85046430387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046430387&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1007285

DO - 10.1371/journal.pgen.1007285

M3 - Article

C2 - 29649218

AN - SCOPUS:85046430387

VL - 14

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 4

M1 - e1007285

ER -